The warning affects all treatments containing GLP-1 receptor agonists, including semaglutide ( Ozempic, Wegovy, Rybelsus ), ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

In addition, in the coming years, oral GLP-1 receptor agonists and injectable formulations that require less-frequent ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

At this time, there are no recommendations to adjust the dose of GLP-1 medications when also taking birth control. Other Oral Medications GLP-1 agonists may affect how other medications taken by ...

Depending on the medication, the effects can last for a minimum of 24 hours to a few weeks. Examples include dulaglutide, ...

In a practice-changing guideline reversal, medical societies advised on Tuesday that most patients do not need to stop taking ...

Pfizer executives are still bullish on the opportunity for its own obesity and diabetes drugs under development, eyeing a potential opening for oral versions and an improved safet ...

This drug class, involving injectable and oral medications used for weight-loss ... of pulmonary aspiration in patients receiving GLP-1 receptor agonists undergoing elective surgeries or ...

Despite crowding in the next-gen weight loss space, Metsera has raised over $500 million since its April launch, indicating a ...

But patients taking GLP-1 drugs did have a greater likelihood of retained gastric contents and of aborted upper endoscopies, ...

Recently the U.S. Food and Drug Administration (FDA) issued updated safety warnings for all glucagon-like peptide 1 receptor ...